Inactive Instrument

News OptimizeRx Corporation Other OTC

Equities

US68401U1051

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Transcript : OptimizeRx Corporation, Q1 2024 Earnings Call, May 14, 2024	May. 14
OptimizeRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 14	CI
Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q1 Revenue $19.7M, vs. Street Est of $18.1M	May. 14	MT
OptimizeRx Reports First Quarter 2024 Financial Results	May. 14	AQ
OptimizeRx to Participate in Upcoming Investor Conferences	May. 06	AQ
OptimizeRx Corporation Provides Earnings Guidance for the First Quarter of 2024	Apr. 29	CI
OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET	Apr. 26	AQ
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report	Apr. 18	AQ
Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 Revenue $28.4M	Apr. 16	MT
Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 EPS $0.26	Apr. 16	MT
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results	Apr. 16	AQ
OptimizeRx Corporation Reiterates Financial Guidance for the Full Year 2024	Apr. 16	CI
OptimizeRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 15	CI
OptimizeRx : ESG Report	Apr. 11	PU
OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row	Apr. 11	AQ
OptimizeRx : Corporate Presentation	Apr. 05	PU
JMP Securities Initiates Coverage on OptimizeRx With Market Perform Rating, $15 Price Target	Apr. 04	MT
OptimizeRx Expected to Meet 2024 Guidance, RBC Says; Shares Drop	Apr. 01	MT
Transcript : OptimizeRx Corporation, Q4 2023 Earnings Call, Mar 28, 2024	Mar. 28
Tranche Update on OptimizeRx Corporation's Equity Buyback Plan announced on March 14, 2023.	Mar. 27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News OptimizeRx Corporation Other OTC

Equities

US68401U1051

Summary

Filters